A Novel Controlled PTEN-Knockout Mouse Model for Prostate Cancer Study

被引:7
|
作者
Liu, Sen [1 ]
Zhang, Bing [1 ,2 ]
Rowan, Brian G. [1 ]
Jazwinski, S. Michal [3 ,4 ]
Abdel-Mageed, Asim B. [5 ]
Steele, Chad [6 ]
Wang, Alun R. [7 ]
Sartor, Oliver [5 ,8 ]
Niu, Tianhua [9 ]
Zhang, Qiuyang [1 ,4 ,8 ]
机构
[1] Tulane Univ, Sch Med, Dept Struct & Cellular Biol, 1430 Tulane Ave, New Orleans, LA 70112 USA
[2] ShenZhen LuoHu Peoples Hosp, Med Lab, Shenzhen, Peoples R China
[3] Tulane Univ, Sch Med, Dept Med, New Orleans, LA 70112 USA
[4] Tulane Univ, Sch Med, Tulane Ctr Aging, 1430 Tulane Ave, New Orleans, LA 70112 USA
[5] Tulane Univ, Sch Med, Dept Urol, New Orleans, LA 70112 USA
[6] Tulane Univ, Sch Med, Dept Microbiol & Immunol, New Orleans, LA 70112 USA
[7] Tulane Univ, Sch Med, Dept Pathol & Lab Med, 1430 Tulane Ave, New Orleans, LA 70112 USA
[8] Tulane Univ, Sch Med, Tulane Canc Ctr, 1430 Tulane Ave, New Orleans, LA 70112 USA
[9] Tulane Univ, Sch Med, Dept Biochem & Mol Biol, 1430 Tulane Ave, New Orleans, LA 70112 USA
基金
美国国家卫生研究院;
关键词
cre-expressing adenovirus; age; prostate cancer; Pten; mouse models; TUMOR-SUPPRESSOR GENE; TRANSGENIC MOUSE; CRE RECOMBINASE; MICE; INACTIVATION; PTEN/MMAC1; EXPRESSION; DELETION; PATHWAY; LEADS;
D O I
10.3389/fmolb.2021.696537
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Prostate cancer (PCa) is associated with advanced age, but how age contributes to prostate carcinogenesis remains unknown. The prostate-specific Pten conditional knockout mouse model closely imitates human PCa initiation and progression. To better understand how age impacts PCa in an experimental model, we have generated a spatially and temporally controlled Pten-null PCa murine model at different ages (aged vs. non-aged) of adult mice. Here, we present a protocol to inject the Cre-expressing adenovirus with luciferin tag, intraductally, into the prostate anterior lobes of Pten-floxed mice; Pten-loss will be triggered post-Cre expression at different ages. In vivo imaging of luciferin signal following viral infection confirmed successful delivery of the virus and Cre activity. Immunohistochemical staining confirmed prostate epithelial-specific expression of Cre recombinase and the loss of Pten and activation of P-Akt, P-S6, and P-4E-BP1. The Cre-expression, Pten ablation, and activated PI3K/AKT/mTOR pathways were limited to the prostate epithelium. All mice developed prostatic epithelial hyperplasia within 4 weeks after Pten ablation and prostatic intraepithelial neoplasia (PIN) within 8 weeks post-Pten ablation. Some PINs had progressed to invasive adenocarcinoma at 8-16 weeks post-Pten ablation. Aged mice exhibited significantly accelerated PI3K/AKT/mTOR signaling and increased PCa onset and progression compared to young mice. The viral infection success rate is similar to 80%. This model will be beneficial for investigations of cancer-related to aging.
引用
收藏
页数:12
相关论文
共 50 条
  • [41] A Nod Scid mouse model to study human prostate cancer
    Bastide, C
    Bagnis, C
    Mannoni, P
    Hassoun, J
    Bladou, F
    PROSTATE CANCER AND PROSTATIC DISEASES, 2002, 5 (04) : 311 - 315
  • [42] Brain metabolic and functional alterations in a liver-specific PTEN knockout mouse model
    Patil, Ishan
    Sancheti, Harsh
    Stiles, Bangyan L.
    Cadenas, Enrique
    PLOS ONE, 2018, 13 (09):
  • [43] Profiling the fecal microbiome of mouse Pten-deficient prostate cancer
    Kura, Yurie
    Sakai, Kazuko
    Fujita, Yoshihiko
    Nozawa, Masahiro
    Yoshikawa, Kazuhiro
    Nishio, Kazuto
    De Velasco, Marco A.
    Uemura, Hirotsugu
    CANCER SCIENCE, 2021, 112 : 261 - 261
  • [44] A novel oncomiR negatively regulates PTEN pathway in prostate cancer
    Bhat, Nadeem S.
    Colden, Melissa
    Arora, Prerna
    Dar, Altaf A.
    Saini, Sharanjot
    Shahryari, Varahram
    Yamamura, Soichiro
    Tanaka, Yuichiro
    Katu, Taku
    Hashimoto, Yutaka
    Shiina, Marisa
    Kulkarni, Priyanka
    Dasgupta, Pritha
    Imai-sumida, Mitsuho
    Maekawa, Shigekatsu
    Deng, Guoren
    Dahiya, Rajvir
    Majid, Shahana
    CANCER RESEARCH, 2017, 77
  • [45] SPOP mutation drives tumorigenesis in mouse prostate - a novel model of ETS negative prostate cancer
    Blattner, Mirjam
    Liu, Deli
    Huang, Dennis
    Gao, Dong
    Sboner, Andrea
    Chen, Yu
    Rubin, Mark A.
    Barbieri, Christopher
    CANCER RESEARCH, 2016, 76
  • [46] A novel mouse model of endometrial cancer: epithelial specific Pten deletion with lactoferrin-iCre
    Daikoku, Takiko
    Terakawa, Jumpei
    Dey, Sudhansu K.
    CANCER RESEARCH, 2015, 75
  • [47] Genes or environment? A novel double knockout mouse model for fetal origins of autism study
    Moussa, Hind N.
    Sibai, Baha M.
    Blackwell, Sean C.
    Fournie, David A.
    Ontiveros, Alejandra E.
    Lu, Fangxian
    Redell, John
    Dash, Pramod
    Longo, Monica
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2016, 214 (01) : S135 - S135
  • [48] Liposome encapsulation of curcumin and resveratrol in combination reduces prostate cancer incidence in PTEN knockout mice
    Narayanan, Narayanan K.
    Nargi, Dominick
    Randolph, Carla
    Narayanan, Bhagavathi A.
    INTERNATIONAL JOURNAL OF CANCER, 2009, 125 (01) : 1 - 8
  • [49] A transgenic mouse prostate cancer model
    Gingrich, JR
    Greenberg, NM
    TOXICOLOGIC PATHOLOGY, 1996, 24 (04) : 502 - 504
  • [50] Quantitative analysis of Pten conditional knockout mouse proteome reveals significant prognostic biomarkers for survival in metastatic castration resistant prostate cancer (CRPC)
    Kaelin, M.
    Cima, I. L.
    Schiess, R.
    Wild, P. J.
    Fankhauser, N.
    Moch, H.
    Aebersold, R.
    Krek, W.
    Cerny, T.
    Gillessen, S.
    EJC SUPPLEMENTS, 2009, 7 (02): : 142 - 142